On 25 October, 25 men and women died in the Central Mediterranean Sea. They were found by the Médecins Sans Frontières’ (MSF) search and rescue ship Bourbon Argos, in an overcrowded rubber boat some 26 nautical miles from the Libyan coastline.


A look into MSF's efforts to accelerate patient-centered TB research. Tuberculosis is now above HIV as one of the deadliest infectious diseases in the world. The most recent the World Health Organization (WHO) Global TB Report by reveals some shocking statistics: each day, 4,900 people die from TB – which is more than three people every minute.


Two new drugs, bedaquiline and delamanid, are proving to be the very last life-line for tuberculosis patients with the most extreme forms of drug resistance. While a few patients benefit from these new drugs in India, many die before being able to access them as they are not widely available.


Through her grandmother’s love, and the help of new DR-TB drug delamanid, a 16-year-old from Khayelitsha has been given a second chance.


Samuel Hanryon (MSF in Paris) is in Calais as the dismantlement approaches. He describes the mood in the jungle as over 7,000 migrants face an uncertain future.


More than two and a half years after the Ebola outbreak officially began, we are now closing our last projects in West Africa dedicated to caring for people who survived the disease.


People in Haiti face a massive health crisis, as the destruction caused by Hurricane Matthew has cut off communities and forced them to live in inhuman conditions.


Seven months after the signature of the EU/Turkey deal, more than 50,000 migrants and refugees still live in substandard conditions in Greece and lack proper access to healthcare.


Find out more about Médecins Sans Frontières/Doctors Without Borders (MSF) work around the world and see what we really do.

This month we look at:


The refugee camp known as ‘La Linière’ in Grande-Synthe, on the outskirts of Dunkirk in northern France, is to close its doors to new arrivals, according to local authorities.